Insider Transactions in Q1 2025 at Blueprint Medicines Corp (BPMC)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 21
2025
|
Kate Haviland CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,446
-0.96%
|
$159,060
$110.24 P/Share
|
|
Jan 21
2025
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
15,161
-3.09%
|
$1,652,549
$109.88 P/Share
|
|
Jan 21
2025
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.63%
|
$360,000
$36.05 P/Share
|
|
Jan 21
2025
|
Christina Rossi CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,274
-0.83%
|
$250,140
$110.39 P/Share
|
|
Jan 13
2025
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
5,000
-3.08%
|
$510,000
$102.28 P/Share
|
|
Jan 13
2025
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.98%
|
$180,000
$36.05 P/Share
|
|
Jan 13
2025
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
2,250
-13.07%
|
$225,000
$100.0 P/Share
|
|
Jan 13
2025
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+11.56%
|
$81,000
$36.05 P/Share
|